CN107897930A - 一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 - Google Patents
一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 Download PDFInfo
- Publication number
- CN107897930A CN107897930A CN201711229083.1A CN201711229083A CN107897930A CN 107897930 A CN107897930 A CN 107897930A CN 201711229083 A CN201711229083 A CN 201711229083A CN 107897930 A CN107897930 A CN 107897930A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- weight
- fish oil
- presbyopia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 230000004438 eyesight Effects 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 45
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000021323 fish oil Nutrition 0.000 claims abstract description 40
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 24
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 24
- 239000007901 soft capsule Substances 0.000 claims abstract description 24
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 24
- 239000011719 vitamin A Substances 0.000 claims abstract description 24
- 229940045997 vitamin a Drugs 0.000 claims abstract description 24
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 23
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 23
- 239000011718 vitamin C Substances 0.000 claims abstract description 23
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 20
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 20
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 20
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 20
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 20
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 20
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 20
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 20
- -1 k-selenocarrageenan Chemical compound 0.000 claims abstract description 20
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 20
- 229940046009 vitamin E Drugs 0.000 claims abstract description 20
- 239000011709 vitamin E Substances 0.000 claims abstract description 20
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 20
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 20
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 18
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 11
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 11
- 229960002477 riboflavin Drugs 0.000 claims abstract description 11
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 11
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- 201000010041 presbyopia Diseases 0.000 claims description 36
- 239000000843 powder Substances 0.000 claims description 29
- 230000036541 health Effects 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 21
- 229920001282 polysaccharide Polymers 0.000 claims description 20
- 239000005017 polysaccharide Substances 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 19
- 239000003826 tablet Substances 0.000 claims description 19
- 239000002775 capsule Substances 0.000 claims description 15
- 239000003292 glue Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 239000004376 Sucralose Substances 0.000 claims description 12
- 229930003270 Vitamin B Natural products 0.000 claims description 12
- 235000015165 citric acid Nutrition 0.000 claims description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 12
- 239000003094 microcapsule Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 12
- 235000019408 sucralose Nutrition 0.000 claims description 12
- 235000019156 vitamin B Nutrition 0.000 claims description 12
- 239000011720 vitamin B Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 108010073771 Soybean Proteins Proteins 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 235000019710 soybean protein Nutrition 0.000 claims description 10
- 235000013871 bee wax Nutrition 0.000 claims description 8
- 239000012166 beeswax Substances 0.000 claims description 8
- 239000000940 FEMA 2235 Substances 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000000686 essence Substances 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims 3
- 230000004377 improving vision Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 230000006872 improvement Effects 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 33
- 210000001508 eye Anatomy 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 8
- 210000001525 retina Anatomy 0.000 description 7
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 231100000027 toxicology Toxicity 0.000 description 3
- 241000132012 Atractylodes Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 240000000950 Hippophae rhamnoides Species 0.000 description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 2
- 241000830535 Ligustrum lucidum Species 0.000 description 2
- 241000169546 Lycium ruthenicum Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000405414 Rehmannia Species 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004240 ciliary body Anatomy 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 210000000554 iris Anatomy 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- 201000009487 Amblyopia Diseases 0.000 description 1
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000010415 Low Vision Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000003138 Pomo dAdamo Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 208000034700 Vitreous opacities Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 208000013469 light sensitivity Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法。该保健品组合物,原料成分为:精制鱼油,维生素E,维生素A,维生素B2,维生素C,葡萄糖酸锌,葡萄糖酸钙,硒酸酯多糖,硫酸铜。本发明保健品组合物制剂为软胶囊、片剂或粉剂。本发明还提供保健品组合物制剂的制备方法。本发明组合物中各组分复配可达到相互协同、增效的作用,具有改善视力、改善老花眼的功能。
Description
技术领域
本发明涉及一种具有改善视力、改善老花眼的保健品组合物、其制剂及制备方法,属于保健品技术领域。
背景技术
老花眼是机体衰老的一种正常表现,是人们步入中老年后由于眼球晶状体硬化,弹性下降,睫状肌收缩能力减退,导致眼睛聚焦能力降低,近距离视野变的模糊。目前针对老花眼的保健品也有报道。CN201310379508提供了一种用于明目的保健品,具有防治老花眼的功能,所述内容物有黑枸杞提取物、人参提取物、熟地黄提取物、菟丝子提取物、女贞子提取物、白术提取物、沙棘提取物、菊花提取物、类胡萝卜素、维生素、矿物质等原料制成的产品,该产品具有补肝肾、益精血、健脾养胃、益气活血、滋肝明目等攻效。具有防治黄斑病变,白内障、青光眼、老花眼、视疲劳、糖尿病视网膜病变、弱视、夜盲症、视力减退、视力模糊、视神经萎缩、玻璃体混浊、迎风流泪等眼疾。此专利中黑枸杞提取物、人参提取物、熟地黄提取物、菟丝子提取物、女贞子提取物、白术提取物、沙棘提取物、菊花提取物常作为中药,不宜长期食用。
维生素是人体健康不可或缺的物质,也是保持眼睛健康、视力正常的重要因素,但是仅采用维生素B和维生素A或C其效果并不理想。目前市场上有较多以维生素A、维生素B或C为原料以补充营养素为目的的保健品,但是专门针对改善老花眼的多种维生素、矿物质的组合物鲜见有研究报道。
发明内容
针对现有技术的不足,本发明提供一种改善视力、改善老花眼的保健品组合物及其制备方法。该保健品具有改善视力、改善老花眼的保健功能。
本发明还提供包含该保健品组合物的制剂及其制备方法。其剂型是软胶囊、片剂和粉剂。
术语说明:
DHA:即二十二碳六烯酸;鱼油的有效成分。
多种维生素:包括维生素E、维生素A、维生素B2、维生素C。
本发明的技术方案如下:
一种改善视力、改善老花眼的保健品组合物,原料成分重量份组成包括:
精制鱼油75~95份,维生素E 0.1~0.5份,维生素A0.01~0.02份,维生素B20.005~0.045份,维生素C 0.05~0.45份,葡萄糖酸锌1~5份,葡萄糖酸钙5~20份,硒酸酯多糖0.005~0.02份,硫酸铜0.05~0.25份。
根据本发明,优选的,所述的保健品组合物,包括以下重量份的原料组成:
精制鱼油80~90份,维生素E 0.2~0.4份,维生素A0.01~0.015份,维生素B20.02~0.04份,维生素C 0.15~0.35份,葡萄糖酸锌1.5~3.5份,葡萄糖酸钙10~15份,硒酸酯多糖0.01~0.015份,硫酸铜0.15~0.2份。
根据本发明最优选的方案之一是,所述原料重量份组成包括:
精制鱼油85份,维生素E 0.35份,维生素A 0.015份,维生素B2 0.035份,维生素C0.25份,葡萄糖酸锌2份,葡萄糖酸钙12.5份,硒酸酯多糖0.012份,硫酸铜0.16份。
根据本发明优选的,所述精制鱼油中,DHA含量为30~50%。质量百分比。
一种改善视力、改善老花眼的保健品组合物的制备方法,将鱼油、维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜混合均匀,即可。
本发明还提供包含该保健品组合物的制剂及其制备方法。所述保健品组合物制剂的剂型为软胶囊、片剂或粉剂。
一、软胶囊
一种改善视力、改善老花眼的保健品组合物软胶囊,包括胶囊壳和包含在胶囊壳内的内容物,其中,所述内容物的有效成分是本发明以上所述的保健品组合物。
优选的,所述软胶囊的内容物还包含辅料蜂蜡。进一步优选的,所述蜂蜡的重量份为3~5份。
优选的,所述软胶囊的胶囊壳由明胶、甘油、水和焦糖色制成。优选的,所述胶囊壳的重量份组成为明胶10~40份、甘油1~20份、水10~50份、焦糖色0.01~0.05份。
一种改善视力、改善老花眼的保健品组合物软胶囊的制备方法,包括步骤:
(1)化胶
按配比,将水和甘油混合,加热至60~80℃,再加入明胶,搅拌至完全溶化,得到均匀的胶液;加入焦糖色,搅拌混合均匀;过滤,在65~75℃下保温,抽真空将胶液中的气泡除去,得胶液;保温静置,备用。
(2)内容物
按配比,将鱼油和蜂蜡混合,65~75℃下保持30~60min,加入维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜,搅拌均匀,过筛,得到胶囊内容物,备用。
(3)压丸
用压丸机将步骤(1)的胶液和步骤(2)的内容物压成软胶囊,干燥12~24h,即得。
本发明的软胶囊,制成规格为1000mg内容物/粒。口服使用。
二、片剂或粉剂
所述改善视力、改善老花眼的保健品组合物片剂或粉剂,以本发明上述的保健品组合物为有效成分,添加辅料制成。其中,
先将鱼油制备成鱼油微囊粉后使用,还需加入片剂辅料或粉剂辅料制成。所述鱼油微囊粉的制备方法,包括步骤:按重量份,将大豆分离蛋白25~55份和麦芽糊精80~180份溶于500-1500份水,混合均匀,再加入精制鱼油75~95份、卵磷脂1~6份,用高速分散器分散,均质,喷雾干燥即得。
优选的,所述片剂辅料包括羟丙甲纤维素、羧甲基淀粉钠、硬脂酸镁、柠檬酸和三氯蔗糖。优选的,按重量份,羟丙甲纤维素为1~8份,羧甲基淀粉钠1~10份,硬脂酸镁1~6份,柠檬酸1~10份,三氯蔗糖0.001~0.002份。
根据本发明,一种改善视力、改善老花眼的保健品组合物片剂的制备方法,包括步骤:
(1)按配比将维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜、羟丙甲纤维素与鱼油微囊粉用混合机混均匀。
(2)将羧甲基淀粉钠配制成一定浓度的溶液,与步骤(1)中混合粉充分混匀制备成湿材。45℃下干燥。
(3)将干燥完的物料粉碎、过筛网,然后与硬脂酸镁、柠檬酸和三氯蔗糖充分混合;压片,控制片重为1000mg/片。
本发明所述粉剂的原料还包含粉剂辅料。优选的,粉剂辅料有香精、柠檬酸和三氯蔗糖。优选的,香精为甜橙、柠檬和水蜜桃中的一种。进一步优选的,按重量份,所述粉剂中香精添加量为0.5~2份,柠檬酸2~12份,三氯蔗糖0.002~0.003份。
根据本发明,一种改善视力、改善老花眼的保健品组合物粉剂的制备方法,包括步骤:
按配比维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜与将鱼油微囊粉混合,再加入辅料香精、柠檬酸、三氯蔗糖、混合均匀。
以上所述软胶囊、片剂和粉剂的制备过程中,未有特别限定的均按本领域现有技术即可。
本发明的技术特点及有益效果:
本发明的改善视力、延缓老花眼的保健品组合物,以精制鱼油、维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜进行复配,通过九种组分的协同增效作用,实现了改善视力、减缓老花眼的保健功能的发明目的。其中:
精制鱼油中富含多种不饱和脂肪酸,其中DHA是视网膜的组成部分,补充足量的DHA能防止视网膜血栓的产生,减缓视网膜变性,缓解眼睛干涩,保护视力。
维生素E、维生素C对光损伤视网膜具有保护作用,对视网膜感光细胞层和外核层有明显的拯救作用。维生素A是合成视网膜上视紫红质的成分,视紫红质光敏感度强,可感弱光,因此,维生素A对于视觉的暗适应方面具有重要的意义。维生素B2缺乏会导致眼睛畏光、流泪、烧疼及发痒、视觉疲劳、眼帘痉挛,适当的补充维生素B2可以增强视力。
葡萄糖酸锌是有机锌补剂,锌是VA代谢的重要金属离子,参与维持眼组织的正常形态及视觉功能。锌缺乏时,可引起视网膜杆体和椎体功能异常。葡萄糖酸钙是有机钙补充剂,钙参与视神经的生理活动,还是眼球充满弹性。钙摄入量不足会使眼肌收缩功能受到影响,眼睛容易紧张、疲劳、视力下降。
硒酸酯多糖是一种含硒的多糖类化合物,是一种有机硒化物,硒在眼睛的睫状体和虹膜中含量最高,在视网膜和色素上皮内含量次之,晶体和玻璃体中含有少量。硒参与支配眼球活动的肌肉收缩、瞳孔的扩大和缩小以及眼辨色力。硫酸铜是铜的膳食补充剂,铜是视网膜色素的组成成分。
本发明保健品组合物种各组分分别从视网膜、眼球、睫状体和虹膜等方面,从组成成分、维持眼睛正常生理功能、预防外界光线等角度保护视力、改善老花眼。另外,组合物的主要成分是维生素和矿物质,是人体所需要的营养素,也是眼组织代谢与维持正常视力所必需的。组合物中各组分复配后可以达到相互协同、增效的作用。经后期人体试食实验证明组合物具有改善视力、改善老花眼的功能。
具体实施方式
下面结合实施例对本发明做进一步的说明,但不限于此。
实施例1、一种改善视力、延缓老花眼的保健品组合物,原料组分如下:
精制鱼油85kg、维生素E 0.35kg、维生素A 0.015kg、维生素B2 0.035kg、维生素C0.25kg、葡萄糖酸锌2kg、葡萄糖酸钙12.5kg、硒酸酯多糖0.012kg、硫酸铜0.08kg。
以上各组分混合均匀,即得组合物。用于动物毒理学实验。
实施例2、一种改善视力、改善老花眼的保健品软胶囊,以实施例1的保健品组合物并添加辅料蜂蜡3.6kg作为内容物,按以下方法制备:
(1)将12kg水和4kg甘油混合搅拌,加热至80~90℃,加入12kg明胶拌至完全溶化,搅拌均匀,得到均匀的胶液混合物;再加入焦糖色0.02kg,搅拌混合均匀;100目筛网过滤后,温度65~75℃,在-0.08~-0.01MPa真空压力下抽真空将胶液中的气泡去除;静置,保温备用。
(2)将85kg鱼油和3.6kg蜂蜡混合,搅拌,66℃下保持40min,加入维生素E 0.35kg、维生素A 0.015kg、维生素B2 0.035kg、维生素C 0.25kg、葡萄糖酸锌2kg、葡萄糖酸钙12.5kg、硒酸酯多糖0.012kg、硫酸铜0.08kg,搅拌均匀,得到胶囊内容物,备用。
(3)用压丸机将步骤(1)的胶液和步骤(2)的内容物压成软胶囊,干燥12~24h,即得。
实施例3、一种改善视力、延缓老花眼的保健品组合物,原料组分如下:
鱼油83kg、维生素E 0.3kg、维生素A 0.012kg、维生素B2 0.03kg、维生素C 0.2kg、葡萄糖酸锌2.5kg、葡萄糖酸钙14kg、硒酸酯多糖0.015kg、硫酸铜0.2kg。
实施例4、一种改善视力、改善老花眼的保健品片剂,以实施例3的保健品组合物作为有效成分并添加片剂辅料(羧甲基淀粉钠、硬脂酸镁、柠檬酸、三氯蔗糖),其中鱼油先加工成鱼油微囊粉后使用,按以下方法制备:
(1)鱼油微囊粉的制备
将42kg大豆分离蛋白和166kg麦芽糊精溶于830kg水,混合均匀,再加入83kg鱼油、2kg卵磷脂,用高速分散器分散,均质,喷雾干燥即得。
(2)所得鱼油微囊粉与0.3kg维生素E、0.012kg维生素A、0.03kg维生素B2、0.2kg维生素C、2.5kg葡萄糖酸锌、14kg葡萄糖酸钙、0.015kg硒酸酯多糖、0.2kg硫酸铜、2kg羟丙甲纤维素用混合机混均匀。
(3)将2kg羧甲基淀粉钠配制成一定浓度的溶液,与步骤(1)中混合粉充分混匀制备成湿材,放置到烘箱中,45℃下干燥。
(4)将干燥完的物料粉碎、过筛网,然后与2kg硬脂酸镁、5kg柠檬酸和0.001kg三氯蔗糖充分混合。压片,控制片重为1000mg/片。
实施例5、一种改善视力、延缓老花眼的保健品组合物,原料组分如下:
鱼油88kg、维生素E0.2kg、维生素A 0.01kg、维生素B2 0.02kg、维生素C0.15kg、葡萄糖酸锌1.5kg、葡萄糖酸钙10kg、硒酸酯多糖0.01kg、硫酸铜0.15kg。
实施例6、一种改善视力、改善老花眼的保健品粉剂,以实施例5的保健品组合物作为原料并添加粉剂辅料(柠檬香精、柠檬酸、三氯蔗糖),其中鱼油加工成鱼油微囊粉后使用;
制备步骤如下:
(1)鱼油微囊粉的制备:将44kg大豆分离蛋白和176kg麦芽糊精溶于900kg水,混合均匀,再加入88kg鱼油、4kg卵磷脂,用高速分散器分散,均质,喷雾干燥即得。
(2)所得鱼油微囊粉中添加0.2kg维生素E、0.01kg维生素A、0.02kg维生素B2、0.15kg维生素C、1.5kg葡萄糖酸锌、10kg葡萄糖酸钙、0.01kg硒酸酯多糖、0.15kg硫酸铜、1kg柠檬香精、6kg柠檬酸、0.003kg三氯蔗糖,混合均匀。
毒理学实验:
实施例1、实施例3、实施例5的组合物样品进行毒理学实验,结果如下:
(1)急性经口毒性试验:对ICR种雌、雄小鼠的最大耐受剂量(MTD)大于18.06g/kg·bw,属无毒级。
(2)三项遗传毒性试验:Ames试验、小鼠骨髓嗜多染红细胞微核试验、小鼠精子畸形试验结果均为阴性。
(3)30天喂养试验:以1.25g/kg·bw、2.50g/kg·bw、5.00g/kg·bw剂量的实施例1、实施例3、实施例5的组合物样品分别给大鼠灌胃30天,实验期间,动物生长发育良好,各剂量组体重、增重、食物利用率、血常规指标、血生化指标、脏器重量及脏器/体重比值与对照组比较,无显著性差异(P>0.05)。大体解剖和组织病理检查未见明显与样品有关的异常改变。提示实施例1、实施例3、实施例5的组合物样品30天喂养对大鼠未见明显毒副作用。
因此,通过急性经口毒性试验、三项遗传毒性试验及30d喂养试验得出实施例1、实施例3、实施例5的组合物样品无明显毒副作用的实验结论。由此可证明本发明改善视力、延缓老花眼的保健品组合物食用安全。
临床实验:
以45~55岁年龄患有老花眼的人群为实验对象,随机选取160人进行临床实验,三个实验组和一个对照组,各40人,各组病例在年龄、病程、临床表现、老花程度等方面经统计学处理无显著性差异。实验组一服用实施例2制得的软胶囊,每次两粒,每日一次,疗程为三个月;实验组二服用实施例4制得的片剂,每日四片,每日一次;实验组三服用实施例6制得的粉剂,每次4g,每日一次;对照组服用与实施例2外观相似内容物为大豆油制作的安慰剂,每次两粒,每日一次。疗程为三个月。
结果显示:经视力检查,实验组一有35人视力较实验前有所提高,视力提高幅度为0.1~0.4;实验组二有34人视力较实验前有所提高,视力提高幅度为0.1~0.4;实验组三有31人视力较实验前有所提高,视力提高幅度为0.1~0.3;对照组有6人视力较实验前有所提高,视力提高0.1。
Claims (9)
1.一种改善视力、改善老花眼的保健品组合物,其特征在于原料成分重量份组成包括:
精制鱼油75~95份,维生素E 0.1~0.5份,维生素A 0.01~0.02份,维生素B2 0.005~0.045份,维生素C 0.05~0.45份,葡萄糖酸锌1~5份,葡萄糖酸钙5~20份,硒酸酯多糖0.005~0.02份,硫酸铜0.05~0.25份。
2.如权利要求1所述的改善视力、改善老花眼的保健品组合物,其特征在于原料重量份组成如下:
精制鱼油80~90份,维生素E 0.2~0.4份,维生素A 0.01~0.015份,维生素B2 0.02~0.04份,维生素C 0.15~0.35份,葡萄糖酸锌1.5~3.5份,葡萄糖酸钙10~15份,硒酸酯多糖0.01~0.015份,硫酸铜0.15~0.2份;
或者,最优选的,所述原料重量份组成如下:
精制鱼油85份,维生素E 0.35份,维生素A 0.015份,维生素B2 0.035份,维生素C 0.25份,葡萄糖酸锌2份,葡萄糖酸钙12.5份,硒酸酯多糖0.012份,硫酸铜0.16份。
3.一种改善视力、改善老花眼的保健品组合物制剂,包括权利要求1或2所述的保健品组合物,制剂的剂型为软胶囊、片剂或粉剂。
4.一种改善视力、改善老花眼的保健品组合物软胶囊,包括胶囊壳和包含在胶囊壳内的内容物,其特征在于所述内容物的有效成分是权利要求1或2所述的保健品组合物。
5.如权利要求4所述的改善视力、改善老花眼的保健品组合物软胶囊,其特征在于,所述软胶囊的内容物还包含辅料蜂蜡;优选的,所述蜂蜡的重量份为4~5份。
6.如权利要求4所述的改善视力、改善老花眼的保健品组合物软胶囊,其特征在于,,所述软胶囊的胶囊壳由明胶、甘油、水和焦糖色制成;优选的,所述胶囊壳的重量份组成为明胶10~50份、甘油1~40份、水10~50份、焦糖色0.01~0.05份。
7.如权利要求4-6任一项所述的改善视力、改善老花眼的保健品组合物软胶囊的制备方法,包括步骤:
(1)化胶
按配比,将水和甘油混合,加热至60~80℃,再加入明胶,搅拌至完全溶化,得到均匀的胶液;加入焦糖色,搅拌混合均匀;过滤,在65~75℃下保温,抽真空将胶液中的气泡除去,得胶液;保温静置;
(2)内容物
按配比,将鱼油和蜂蜡混合,65~75℃下保持30~60min,加入维生素E、维生素A、维生素B2、维生素C、葡萄糖酸锌、葡萄糖酸钙、硒酸酯多糖、硫酸铜,搅拌均匀,过筛,得到胶囊内容物;
(3)压丸
用压丸机将步骤(1)的胶液和步骤(2)的内容物压成软胶囊,干燥12~24h,即得;
软胶囊制成规格为1000mg内容物/粒。
8.一种改善视力、改善老花眼的保健品组合物片剂,以权利要求1或2的保健品组合物为有效成分,添加辅料制成;
所述鱼油制备成鱼油微囊粉,包括:按重量份,将大豆分离蛋白25~55份和麦芽糊精80~180份溶于500-1200份水,混合均匀,再加入精制鱼油75~95份、卵磷脂1~6份,用高速分散器分散,均质,喷雾干燥即得;
所述片剂辅料包括羟丙甲纤维素、羧甲基淀粉钠、硬脂酸镁、柠檬酸和三氯蔗糖。
9.一种改善视力、改善老花眼的保健品组合物粉剂,以权利要求1或2的保健品组合物为有效成分,添加辅料制成;其中,
所述鱼油制备成鱼油微囊粉,包括:按重量份,将大豆分离蛋白25~55份和麦芽糊精80~180份溶于500-1200份水,混合均匀,再加入精制鱼油75~95份、卵磷脂1~6份,用高速分散器分散,均质,喷雾干燥即得;
所述粉剂辅料有香精、柠檬酸和三氯蔗糖。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711229083.1A CN107897930A (zh) | 2017-11-29 | 2017-11-29 | 一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711229083.1A CN107897930A (zh) | 2017-11-29 | 2017-11-29 | 一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107897930A true CN107897930A (zh) | 2018-04-13 |
Family
ID=61849302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711229083.1A Pending CN107897930A (zh) | 2017-11-29 | 2017-11-29 | 一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107897930A (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524448A (zh) * | 2003-02-27 | 2004-09-01 | 郑春山 | 一种保护视力的营养保健食品及其制造方法 |
CN1593253A (zh) * | 2004-06-21 | 2005-03-16 | 杭州娃哈哈集团有限公司 | 一种视力保健饮料 |
CN1757409A (zh) * | 2005-09-20 | 2006-04-12 | 上海泰运科技有限公司 | 万寿胶囊的配方及保健功能 |
AU2008300328A1 (en) * | 2007-09-19 | 2009-03-26 | Ophthalmopharma Ag | Nutritional supplement formulations and fortified foods comprising such supplements |
CN101583351A (zh) * | 2006-12-15 | 2009-11-18 | 诺瓦提斯公司 | 治疗眼病的营养补充组合物 |
CN101612161A (zh) * | 2009-08-07 | 2009-12-30 | 魏谠全 | 一种眼药组合物及其制剂 |
CN101785854A (zh) * | 2010-02-11 | 2010-07-28 | 石家庄惠仕医药保健品有限公司 | 叶黄素多维营养保健药物组合物、其制备方法及应用 |
CN101953429A (zh) * | 2009-07-21 | 2011-01-26 | 天津滨海索尔特生物技术中心有限公司 | 海水鱼营养强化微胶囊水剂及其制备方法 |
CN102669649A (zh) * | 2011-03-14 | 2012-09-19 | 广州加原医药科技有限公司 | 一种缓解视疲劳的组合物 |
CN104666370A (zh) * | 2013-11-30 | 2015-06-03 | 烟台巨先药业有限公司 | 一种深海鱼油软胶囊及其制备方法 |
CN105309927A (zh) * | 2014-07-18 | 2016-02-10 | 周子童 | 一种含叶黄素的复方保健品 |
-
2017
- 2017-11-29 CN CN201711229083.1A patent/CN107897930A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524448A (zh) * | 2003-02-27 | 2004-09-01 | 郑春山 | 一种保护视力的营养保健食品及其制造方法 |
CN1593253A (zh) * | 2004-06-21 | 2005-03-16 | 杭州娃哈哈集团有限公司 | 一种视力保健饮料 |
CN1757409A (zh) * | 2005-09-20 | 2006-04-12 | 上海泰运科技有限公司 | 万寿胶囊的配方及保健功能 |
CN101583351A (zh) * | 2006-12-15 | 2009-11-18 | 诺瓦提斯公司 | 治疗眼病的营养补充组合物 |
AU2008300328A1 (en) * | 2007-09-19 | 2009-03-26 | Ophthalmopharma Ag | Nutritional supplement formulations and fortified foods comprising such supplements |
CN101953429A (zh) * | 2009-07-21 | 2011-01-26 | 天津滨海索尔特生物技术中心有限公司 | 海水鱼营养强化微胶囊水剂及其制备方法 |
CN101612161A (zh) * | 2009-08-07 | 2009-12-30 | 魏谠全 | 一种眼药组合物及其制剂 |
CN101785854A (zh) * | 2010-02-11 | 2010-07-28 | 石家庄惠仕医药保健品有限公司 | 叶黄素多维营养保健药物组合物、其制备方法及应用 |
CN102669649A (zh) * | 2011-03-14 | 2012-09-19 | 广州加原医药科技有限公司 | 一种缓解视疲劳的组合物 |
CN104666370A (zh) * | 2013-11-30 | 2015-06-03 | 烟台巨先药业有限公司 | 一种深海鱼油软胶囊及其制备方法 |
CN105309927A (zh) * | 2014-07-18 | 2016-02-10 | 周子童 | 一种含叶黄素的复方保健品 |
Non-Patent Citations (6)
Title |
---|
ELISA_SU: "ENERZONA OMEGA 3意大利顶级深海鱼油", 《百度 HTTPS://WEIBO.COM/2678305930/FXBYIVUDA?TYPE=COMMENT#_RND1615513770784》 * |
康锁彬: "《老年生活400问》", 31 March 1996, 河北科学技术出版社 * |
朱燕中: "《最全最实用的小偏方》", 31 January 2017, 沈阳:辽宁科学技术出版社 * |
朱迅涛 等: "以大豆蛋白制备微胶囊化鱼油的研究(Ⅰ)——微胶囊化鱼油的壁材选择", 《中国油脂》 * |
梁艺英: "《保健食品研发与审评》", 30 November 2012, 北京:中国医药科技出版社 * |
黄世敬: "《轻松降血脂》", 31 March 2015, 北京:金盾出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050202104A1 (en) | Method of enhancement of cognitive skills | |
CN105077236B (zh) | 辅助降血糖的青稞复合特膳营养粉及其制备方法 | |
CN101904502B (zh) | 复方叶黄素软胶囊及制备方法 | |
CN108157568A (zh) | 一种缓解视疲劳的组合糖果及其制备方法和用途 | |
CN102727586A (zh) | 预防和治疗糖尿病的组合物 | |
CN105192696A (zh) | 一种保护眼底、营养视网膜及抵御蓝光损伤的组合物及其制备方法 | |
CN103735616A (zh) | 一种用于保护视力的微囊化制剂及其制备方法 | |
CN103083270B (zh) | 一种叶黄素咀嚼片 | |
CN104474018A (zh) | 一种缓解视疲劳的保健软胶囊 | |
CN102048884B (zh) | 一种含瓜拉那提取物的减肥组合物 | |
CN108041609B (zh) | 一种具有缓解视疲劳、预防近视的食品组合物及其制备方法 | |
CN109430856A (zh) | 一种养护眼睛改善视疲劳的保健食品配方及其制备方法 | |
CN106109737A (zh) | 一种抗氧化的营养制剂及其制备方法 | |
CN105963411A (zh) | 一种缓解视疲劳的中药组合物及其制剂和制法 | |
EP1637149A1 (de) | Nahrungsergänzungsmittel für den Mann | |
EP1520584A1 (en) | Composition for the activation of the immune system | |
CN107897930A (zh) | 一种改善视力、改善老花眼的保健品组合物、其制剂及制备方法 | |
CN100427103C (zh) | 一种海洋生物活性组合物及其用途 | |
CN109123674A (zh) | 一种黑果枸杞复方缓解视疲劳片以及其制备工艺 | |
CN105983006A (zh) | 一种缓解视疲劳的组合物及制备方法 | |
CN104324278A (zh) | 一种减肥药及减肥冲剂的生产方法 | |
WO2019047141A1 (zh) | 控制血糖的药物组合物 | |
EP1457209A1 (en) | Composition for the enhancement of cognitive skills comprising Panax ginseng and Paullinia cupana extracts | |
CN103006920A (zh) | 一种祛黄褐斑纯中药药物组合及其制备方法 | |
RU2270583C2 (ru) | Биологически активная добавка к пище для профилактики нарушений и коррекции зрения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |